Gilead Sciences (GILD) Earnings Date, Estimates & Call Transcripts → Bigger Than NVIDIA? (From Behind the Markets) (Ad) Free GILD Stock Alerts $64.27 -0.79 (-1.21%) (As of 06/17/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateAug. 1EstimatedActual EPS (Apr. 25) -$1.32 Beat By $0.17 Consensus EPS (Apr. 25) -$1.49 Read Call TranscriptListen to Call Get Gilead Sciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for GILD and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueGILD Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GILD Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Behind the MarketsThe Military's $700M "AI Software Bullet"The Pentagon is spending over $700 MILLION on a top-secret project called "Overmatch." It's a software-defined networking solution that will connect all sensors, weapons, platforms, and personnel across our military branches.Get the name and stock ticker of this critical military tech firm HERE>>> Gilead Sciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20244($1.42)$1.97$0.94 Q2 20244$1.51$1.98$1.75 Q3 20244$1.75$2.10$1.91 Q4 20244$1.79$1.86$1.84 FY 202416$3.63$7.91$6.43 Q1 20251$1.59$1.59$1.59 Q2 20251$1.67$1.67$1.67 Q3 20251$2.06$2.06$2.06 Q4 20251$1.86$1.86$1.86 FY 20254$7.18$7.18$7.18 Q1 20261$1.56$1.56$1.56 GILD Earnings Date and InformationGilead Sciences last announced its quarterly earnings data on April 25th, 2024. The biopharmaceutical company reported ($1.32) EPS for the quarter, beating analysts' consensus estimates of ($1.49) by $0.17. The firm earned $6.69 billion during the quarter, compared to the consensus estimate of $6.36 billion. Its revenue for the quarter was up 5.3% on a year-over-year basis. Gilead Sciences has generated $0.36 earnings per share over the last year ($0.36 diluted earnings per share) and currently has a price-to-earnings ratio of 178.5. Earnings for Gilead Sciences are expected to grow by 92.80% in the coming year, from $3.75 to $7.23 per share. Gilead Sciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.Read More Gilead Sciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/1/2024(Estimated)------- 4/25/2024Q1 2024($1.49)($1.32)+$0.17$0.70$6.36 billion$6.69 billion 2/6/2024Q4 2023$1.76$1.72($0.04)$2.30$7.10 billion$7.12 billion 11/7/2023Q3 2023$1.91$2.29+$0.38$2.85$6.81 billion$7.05 billion 8/3/2023Q2 2023$1.64$1.34($0.30)$1.85$6.45 billion$6.60 billion 4/27/2023Q1 2023$1.63$1.37($0.26)$1.94$6.33 billion$6.35 billion 2/2/2023Q4 2022$1.50$1.67+$0.17$2.04$6.63 billion$7.39 billion Get the Latest News and Ratings for GILD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gilead Sciences and its competitors with MarketBeat's FREE daily newsletter. 10/27/2022Q3 2022$1.44$1.90+$0.46$2.38$6.12 billion$7.04 billion8/2/2022Q2 2022$1.51$1.58+$0.07$2.25$5.88 billion$6.26 billion4/28/2022Q1 2022$1.77$2.12+$0.35$4.22$6.28 billion$6.59 billion 2/1/2022Q4 2021$1.53$0.69($0.84)$1.08$6.64 billion$7.24 billion 10/28/2021Q3 2021$1.72$2.65+$0.93$3.25$6.31 billion$7.42 billion 7/29/2021Q2 2021$1.76$1.87+$0.11$2.53$6.15 billion$6.22 billion 4/29/2021Q1 2021$2.06$2.08+$0.02$2.79$6.78 billion$6.42 billion 2/4/2021Q4 2020$2.15$2.19+$0.04$3.15$7.11 billion$7.42 billion 10/28/2020Q3 2020$1.90$2.11+$0.21$3.93$6.20 billion$6.58 billion 7/30/2020Q2 2020$1.57$1.11($0.46)$4.88$5.24 billion$5.14 billion 4/30/2020Q1 2020$1.57$1.68+$0.11$2.14$5.44 billion$5.55 billion 2/4/2020Q4 2019$1.67$1.30($0.37)$0.08$5.74 billion$5.88 billion 10/24/2019Q3 2019$1.74$1.75+$0.01$4.22$5.61 billion$5.60 billion 7/30/2019Q2 2019$1.68$1.82+$0.14$1.97$5.54 billion$5.69 billion Gilead Sciences Earnings - Frequently Asked Questions When is Gilead Sciences's earnings date? Gilead Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on GILD's earnings history. Did Gilead Sciences beat their earnings estimates last quarter? In the previous quarter, Gilead Sciences (NASDAQ:GILD) reported ($1.32) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.49) by $0.17. Learn more on analysts' earnings estimate vs. GILD's actual earnings. How can I listen to Gilead Sciences's earnings conference call? The conference call for Gilead Sciences's latest earnings report can be listened to online. Listen to Conference Call How can I read Gilead Sciences's conference call transcript? The conference call transcript for Gilead Sciences's latest earnings report can be read online. Read Transcript How much revenue does Gilead Sciences generate each year? Gilead Sciences (NASDAQ:GILD) has a recorded annual revenue of $27.12 billion. How much profit does Gilead Sciences generate each year? Gilead Sciences (NASDAQ:GILD) has a recorded net income of $5.67 billion. GILD has generated $0.36 earnings per share over the last four quarters. What is Gilead Sciences's price-to-earnings ratio? Gilead Sciences (NASDAQ:GILD) has a trailing price-to-earnings ratio of 178.53 and a forward price-to-earnings ratio of 17.14. The price/earnings-to-growth ratio is 1.3. What is Gilead Sciences's EPS forecast for next year? Gilead Sciences's earnings are expected to grow from $3.75 per share to $7.23 per share in the next year, which is a 92.80% increase. More Earnings Resources from MarketBeat Related Companies: MRNA Earnings Date SGEN Earnings Date TECH Earnings Date QGEN Earnings Date CRSP Earnings Date DNLI Earnings Date AMGN Earnings Date VRTX Earnings Date REGN Earnings Date BIIB Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple Stock All-Time Highs: Can AI Outweigh Earnings Jitters?CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry Shifts This page (NASDAQ:GILD) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | Sponsoredonly trade options on these 5-7 stocksI'm going to reveal the only 5-7 stocks you should be trading. But here's the secret - there's nothing spec...Prosper Trading Academy | SponsoredInflation Is Robbing You Blind! Here’s How to Fight Back!Quietly, inflation has reduced your purchasing power by 29.4% since 2014. So something that cost $100 in 20...American Alternative | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredBiden out June 13; replacement chosen?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gilead Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gilead Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.